CVR Partners saw its IBD SmartSelect Composite Rating jump to 96 Monday, up from 92 the day before. The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's a good starting point when looking for the best stocks to buy and watch. CVR Partners is currently about 3% above a 93.73 entry from a flat base. Understand that it's a thinly traded stock, with average daily dollar volume under $8 million. Less liquid stocks are more prone to volatile action since it takes fewer shares traded to move the share price significantly. The stock sports a 95 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 95% of all stocks. Its Accumulation/Distribution Rating of A- shows heavy buying by institutional investors, such as mutual funds and pension funds, over the last 13 weeks. The company reported a 48% increase in earnings for Q2. Top line growth increased 27%, up from 12% in the prior report. The company has now posted accelerating growth in each of the last five quarters. CVR Partners earns the No. 1 rank among its peers in the Chemicals-Agriculture industry group. CF Industries Holdings and Intrepid Potash are also among the group's highest-rated stocks.

CVR Partners Joins Elite List Of Stocks With 95-Plus Composite Rating

CVR Partners' IBD SmartSelect Composite Rating increased to 96, indicating strong performance relative to other stocks. The company reported a 48% Q2 earnings increase with 27% top-line growth, and has posted accelerating growth for five consecutive quarters. It ranks No. 1 in the Chemicals-Agriculture industry group, alongside CF Industries Holdings and Intrepid Potash.